NCT05863130View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 764198 is Processed in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

November 9, 2023

Study Completion Date

November 9, 2023

Conditions
Healthy
Interventions
DRUG

BI 764198 (C-14) (approach 1)

BI 764198 (C-14) (approach 1)

DRUG

BI 764198 (C-14) (approach 2)

BI 764198 (C-14) (approach 2)

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY